iStock 000017122847Large mapol

Medical Cannabis: Equal Access for All?
Session Date: Tuesday, April 17, 2018 07:30 to 08:30
Breakfast Session 5, Ballroom Level, Room 501/502

Panelists:
• Johnny Ma, Mapol Inc.
• Philippe Lucas, Tilray (Moderator)
• Dr. Bruno Battistini, New Brunswick Health Research Foundation
• Jonathan Zaid, Canadians for Fair Access to Medical Marijuana

The Canadian landscape for medical cannabis is quickly evolving, with a rapid increase in credible clinical evidence for its utilization for different medical conditions. There is increased awareness and demand from Canadian patients for timely, accessible, and affordable medical cannabis for appropriate use, but multiple barriers continue to exist, including suboptimal coverage by public and private payer plans. The objectives of this panel discussion will be the following:

  • To present evidence on the appropriateness, effectiveness, and accessibility of medical cannabis for Canadians with medical conditions.
  • To present the real-world findings of an evaluative framework used by Canadian payers for the timely and appropriate access to medical cannabis.
  • To hear the patient voice on how improving reimbursement of medical cannabis improves appropriate, accessible, and affordable patient care, which can reduce reliance on other prescription drugs.

Mapol Inc. is proud to be a Platinum Sponsor at the 2018 CADTH Symposium in Halifax, N.S. April 16-17, 2018.

Download the 2018 Program for the CADTH Symposium.  

Poster Presentation: A Review of CDR Recommendations for Manufacturer Resubmissions

 

2017Outlookv1

 On December 5th, Mapol hosted the 4th Annual Benefits Advisors’ Drug Plan Outlook in Toronto. This event brought together industry thought leaders from the benefits advisor and innovative pharmaceutical manufacturer communities from across Canada. With a shared objective of improving the plan sponsor and plan member experience with drug benefit coverage, there was agreement that more work is needed in 2018 to minimize the potential consequences resulting from legacy administrative practices or drug plan changes.

Key takeaways included the need for greater transparency in the premium setting process and the avoidance of unilateral contract changes with little choice for plan sponsors. To support employee health, there was an expressed need to allow plan members to stay on existing treatments without being forced to switch to different drugs as a result of changes to plan designs and/or transfers of contracts from one insurer to another. Participants at the meeting also felt that insurers can be active partners in the delivery and support of disease information to plan members and their dependents.

The proceedings of this event will be published in an upcoming edition of Benefits and Pensions Monitor.

Mapol Inc. will be hosting our 8th Annual Private Payer Education and Training Seminar in Toronto/Brampton on Wednesday November 15, 2017This will be an opportunity for you to hear from key stakeholders about new developments being implemented and/or considered for private drug plans. Also, Mapol will be highlighting key trends and issues for 2017. 
Last Day to Register is Friday November 10, 2017!

 Confirmed Stakeholder Speakers Toronto Full-Day Session Includes:

  • Joan Weir, Director, Health and Disability Policy, Canadian Life and Health Insurance Association Inc., An Overview of CLHIA Initiatives: PMPRB Reform, CADTH Changes, OHIP+ Transition, and Pharmacogenomics in Private Plans
  • Jean Lachaine, PeriPharm Inc., Economic Evaluation of New Medications to Support Private Payers Reimbursement Decisions
  • Tim Clarke, BMath FSA FCIA, President, tc Health Consulting, Plan Sponsor Concerns/Issues
  • Johnny Ma, President, Mapol Inc., Review of 2017 Trends & Issues
  • Atul Goela, B.Sc. Phm., R.Ph, Director, Possibilities & Partnerships – Digital Health Solutions, Sun Life Financial, Digital Health Trends
  • Dr. Luc Boileau, M.D., M. Sc. Adm. S., FRCPC, President and CEO and Sylvie Bouchard, BPharm, Diploma in Hospital Pharmacy, MSc, MBA, Director of Medication, INESSS, Ongoing Changes in the Management of Innovation: Perspectives from INESSS

EVENT FEE: $995.00 + HST per person. 

REGISTER FOR TORONTO                          MONTRÉAL --> POSTPONED TO 2018
TORONTO - WEDNESDAY NOVEMBER 15, 2017         MONTRÉAL
Hilton Garden Inn Toronto/Brampton                        Marriott Montreal Airport In-Terminal Hotel
2648 Steeles Avenue East                                          800 Place Leigh Capreol
Brampton, ON, L6S 6J9                                              Dorval, QC, H4Y 0A4
(905) 595-5151                                                              (514) 636-6700
Map and Directions                                             

GROUP DISCOUNT SPECIAL UNTIL FRIDAY OCTOBER 27, 2017: Register three attendees and get the fourth free. That's a savings of $995 + HST. Contact Sue-Lee Pring (spring@mapol.cafor special group registration. More details.

These are closed-door seminars for brand pharmaceutical manufacturers. Given that this event has become very popular, we encourage you to register your spot as soon as possible because seating is limited. 

Johnny Ma, Gord Polk and Robert Fong are representing Mapol at the 2017 CADTH Symposium
Download the CADTH brochure

 

 

Page 1 of 6

Search